|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-2-13
|
|
pubmed:abstractText |
BACKGROUND Chronic plaque psoriasis is associated with overweight or obesity. Anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatments are now frequently used in psoriasis management. TNF-alpha is deeply involved in body weight homeostasis, which may be affected by TNF-alpha-targeted therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1468-3083
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
341-4
|
|
pubmed:meshHeading |
pubmed-meshheading:18005022-Adult,
pubmed-meshheading:18005022-Aged,
pubmed-meshheading:18005022-Antibodies, Monoclonal,
pubmed-meshheading:18005022-Antirheumatic Agents,
pubmed-meshheading:18005022-Body Mass Index,
pubmed-meshheading:18005022-Chronic Disease,
pubmed-meshheading:18005022-Cohort Studies,
pubmed-meshheading:18005022-Female,
pubmed-meshheading:18005022-Homeostasis,
pubmed-meshheading:18005022-Humans,
pubmed-meshheading:18005022-Immunoglobulin G,
pubmed-meshheading:18005022-Male,
pubmed-meshheading:18005022-Methotrexate,
pubmed-meshheading:18005022-Middle Aged,
pubmed-meshheading:18005022-Psoriasis,
pubmed-meshheading:18005022-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:18005022-Retrospective Studies,
pubmed-meshheading:18005022-Tumor Necrosis Factor-alpha,
pubmed-meshheading:18005022-Weight Gain
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
|
|
pubmed:affiliation |
Section of Dermatology, Department of Biomedical and Surgical Science, University of Verona, Verona, Italy. paolo.gisondi@univr.it
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
